Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Infectious Disease Therapeutics Market Report 2024

Infectious Disease Therapeutics Global Market Report 2024 – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Infectious Disease Therapeutics Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : June 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Infectious Disease Therapeutics Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Infectious Disease Therapeutics Market Definition And Segments

Infectious disease therapeutics refers to the various treatments and interventions aimed at combating illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. The goal of infectious disease therapeutics is to either eliminate the infectious agent from the body or to control its replication and spread, thereby alleviating symptoms, preventing complications, and ultimately promoting recovery.

The main types of infectious disease therapeutics are drugs and vaccines. Vaccines are biological preparations that stimulate the immune system to recognize and fight specific infectious agents. The various diseases include tuberculosis, HIV/aids, influenza, hepatitis, and others that are used by various end-users such as hospitals and clinics, retail pharmacies, research organizations, and others.

The infectious disease therapeutics market covered in this report is segmented –

1) By Type: Drugs, Vaccines

2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases

3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users

The infectious disease therapeutics market size has grown strongly in recent years. It will grow from $132.14 billion in 2023 to $141.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, increasing incidence of viral diseases, growing awareness about diagnosis, rising demand for efficient and quick diagnostic testing, growing demand for cost-effective generic drugs, growing prevalence of infectious diseases, growing importance of antimicrobial stewardship.

The infectious disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $184.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing investments, expansion of clinical trial studies, increasing number of clinical trials, increasing focus on infectious disease prevention, increasing awareness about early diagnosis, growing awareness and funding. Major trends in the forecast period include partnerships, product approvals, investments, and research and developments in therapeutics.

Infectious Diseases On The Upswing A Global Health Concern

The rising prevalence of infectious diseases is expected to propel the growth of the infectious disease therapeutics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. The rising infectious diseases are due to several key factors such as climate change and environmental disruption, antimicrobial resistance, weakened immune systems, increased interactions with animals, and ecological disturbances. Infectious disease therapeutics play a vital role in treating infections, reducing morbidity and mortality, and controlling the spread of communicable diseases within communities and across populations. For instance, according to the gov. uk, a UK-based public sector information website, in England, there were 3,805 new HIV diagnoses in 2022, marking a 22% increase from the 3,118 cases reported in 2021 and a 26% rise from the 3,026 cases reported in 2020. Therefore, the rising prevalence of infectious diseases drives the infectious disease therapeutics market.

Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.

Corporate Initiatives In Infectious Disease Therapeutics Advancing Treatment, Resisting Resistance, and Promoting Global Health Equity

Major companies operating in the infectious disease therapeutics market are investing in infectious disease drugs to develop more effective treatments, combat antimicrobial resistance, expand their product portfolios, and address emerging infectious threats. These investments aim to improve patient outcomes, meet unmet medical needs, and contribute to global public health efforts to control and manage infectious diseases. For instance, in June 2022, GSK, a UK-based healthcare company invested £1 billion(USD 1.09 billion) to proactively address infectious diseases in lower-income countries. This initiative aims to enhance research and development efforts to combat diseases that disproportionately affect these regions. The disparity in health research funding and resources between high-income and low- and middle-income countries underscores the urgency for such proactive investments to improve population health equitably. 

OPKO Health Expands Infectious Disease Therapeutics Portfolio Through Acquisition of Modex Therapeutics

In May 2022, OPKO Health, a US-based healthcare company acquired Modex Therapeutics for $300 million. The acquisition significantly broadened OPKO's technology foundation and expanded its product pipeline into new therapeutic areas, particularly oncology and infectious diseases. Modex Therapeutics is a US-based biotechnology company that manufactures infectious disease therapeutics.

North America was the largest region in the infectious disease therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infectious disease therapeutics market consists of sales of antibiotics, antivirals, and immunotherapies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The infectious disease therapeutics market research report is one of a series of new reports from The Business Research Company that provides infectious disease therapeutics market statistics, including infectious disease therapeutics industry global market size, regional shares, competitors with an infectious disease therapeutics market share, detailed infectious disease therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the infectious disease therapeutics industry. This infectious disease therapeutics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Infectious Disease Therapeutics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $141.08 billion
Revenue Forecast In 2033 $184.17 billion
Growth Rate CAGR of 6.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Infectious Disease Therapeutics Market Characteristics

    3. Infectious Disease Therapeutics Market Trends And Strategies

    4. Infectious Disease Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Infectious Disease Therapeutics Market Size and Growth

    5.1. Global Infectious Disease Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Infectious Disease Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Infectious Disease Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Infectious Disease Therapeutics Market Segmentation

    6.1. Global Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Drugs

    Vaccines

    6.2. Global Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Tuberculosis

    HIV/AIDS

    Influenza

    Hepatitis

    Other Diseases

    6.3. Global Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Clinics

    Retail Pharmacies

    Research Organizations

    Other End Users

    7. Infectious Disease Therapeutics Market Regional And Country Analysis

    7.1. Global Infectious Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Infectious Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Infectious Disease Therapeutics Market

    8.1. Asia-Pacific Infectious Disease Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Infectious Disease Therapeutics Market

    9.1. China Infectious Disease Therapeutics Market Overview

    9.2. China Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Infectious Disease Therapeutics Market

    10.1. India Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Infectious Disease Therapeutics Market

    11.1. Japan Infectious Disease Therapeutics Market Overview

    11.2. Japan Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Infectious Disease Therapeutics Market

    12.1. Australia Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Infectious Disease Therapeutics Market

    13.1. Indonesia Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Infectious Disease Therapeutics Market

    14.1. South Korea Infectious Disease Therapeutics Market Overview

    14.2. South Korea Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Infectious Disease Therapeutics Market

    15.1. Western Europe Infectious Disease Therapeutics Market Overview

    15.2. Western Europe Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Infectious Disease Therapeutics Market

    16.1. UK Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Infectious Disease Therapeutics Market

    17.1. Germany Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Infectious Disease Therapeutics Market

    18.1. France Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Infectious Disease Therapeutics Market

    19.1. Italy Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Infectious Disease Therapeutics Market

    20.1. Spain Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Infectious Disease Therapeutics Market

    21.1. Eastern Europe Infectious Disease Therapeutics Market Overview

    21.2. Eastern Europe Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Infectious Disease Therapeutics Market

    22.1. Russia Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Infectious Disease Therapeutics Market

    23.1. North America Infectious Disease Therapeutics Market Overview

    23.2. North America Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Infectious Disease Therapeutics Market

    24.1. USA Infectious Disease Therapeutics Market Overview

    24.2. USA Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Infectious Disease Therapeutics Market

    25.1. Canada Infectious Disease Therapeutics Market Overview

    25.2. Canada Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Infectious Disease Therapeutics Market

    26.1. South America Infectious Disease Therapeutics Market Overview

    26.2. South America Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Infectious Disease Therapeutics Market

    27.1. Brazil Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Infectious Disease Therapeutics Market

    28.1. Middle East Infectious Disease Therapeutics Market Overview

    28.2. Middle East Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Infectious Disease Therapeutics Market

    29.1. Africa Infectious Disease Therapeutics Market Overview

    29.2. Africa Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Infectious Disease Therapeutics Market Competitive Landscape And Company Profiles

    30.1. Infectious Disease Therapeutics Market Competitive Landscape

    30.2. Infectious Disease Therapeutics Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Roche Diagnostics Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Sanofi SA

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Infectious Disease Therapeutics Market Other Major And Innovative Companies

    31.1. Thermo Fisher Scientific

    31.2. AstraZeneca

    31.3. Abbott Laboratories

    31.4. Novartis International AG

    31.5. Danaher Corporation

    31.6. GlaxoSmithKline plc

    31.7. Gilead Sciences Inc.

    31.8. Janssen Pharmaceutical

    31.9. Siemens Healthineers

    31.10. Moderna Inc.

    31.11. Becton, Dickinson, and Company

    31.12. Regeneron Pharmaceuticals Inc.

    31.13. Boehringer Ingelheim GmbH

    31.14. BioMérieux SA

    31.15. Sysmex Corporation

    32. Global Infectious Disease Therapeutics Market Competitive Benchmarking

    33. Global Infectious Disease Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Infectious Disease Therapeutics Market

    35. Infectious Disease Therapeutics Market Future Outlook and Potential Analysis

    35.1 Infectious Disease Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 Infectious Disease Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 Infectious Disease Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Infectious Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Infectious Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Roche Diagnostics Corporation Financial Performance
  • Table 76: F. Hoffmann-La Roche AG Financial Performance
  • Table 77: Merck & Co. Inc. Financial Performance
  • Table 78: Sanofi SA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Infectious Disease Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Infectious Disease Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Infectious Disease Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Infectious Disease Therapeutics Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Infectious Disease Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Roche Diagnostics Corporation Financial Performance
  • Figure 76: F. Hoffmann-La Roche AG Financial Performance
  • Figure 77: Merck & Co. Inc. Financial Performance
  • Figure 78: Sanofi SA Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Infection Prevention Global Market Report 2024 – By Product (Sterilization Equipment, Disinfectors, Consumables), By Infection Type (Microbial Infections, Healthcare Associated Infections), By End User (Hospitals And Clinics, Pharmaceutical Companies, Clinical Laboratories, Medical Device Companies, Life Science Industry, Academic And Research Center) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Infection Control Supplies Global Market Report 2024 – By Product Type (Disinfectant, Medical Face Mask, Surgical Cap, Surgical Gown, Medical Gloves), By Distribution Channel (Wholesalers, Retailers, Pharmacies, E-Commerce, Other Channels), By End-Use (Hospitals And Clinics, Medical Device Companies, Pharmaceutical Companies, Research Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Infection Control Global Market Report 2024 – By Type (Disinfectors, Sterilization, Equipment, Consumables And Accessories, Services), By Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), By Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Other Applications), By End User (Hospitals And Clinics, Medical Device Companies, Pharmaceutical Companies, Life Science Industry, Food Industry, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hospital-Acquired Infection Control Global Market Report 2024 – By Product (Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products), By Technology (Phenotypic Methods, Genotypic Methods), By Diseases (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases), By Application (Disease Testing, Drug-Resistance Testing), By End User (Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Hospital Acquired Infections Testing Kits Global Market Report 2024 – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumonia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others), By Pathogen Type (Viral, Bacterial, Fungal), By Application (Drug Resistance Testing, Disease Testing) – Market Size, Trends, And Global Forecast 2024-2033
View Report
High Level Disinfection Services Global Market Report 2024 – By Services( In House, Outsource), By Compound( Formaldehyde, Glutaraldehyde, Ortho-Phthalaldehyde, Hydrogen Peroxide, Peracetic Acid, Other Components), By End-User( Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Infectious Disease Diagnostics Global Market Report 2024 – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-Producing animals), By Technology (Immunodiagnostics, Molecular Diagnostic, Other Technologies), By End User (Reference Laboratories, Veterinary Hospitals and Clinics, Point of Care, Research Institutes and Universities, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Anti-infectives Global Market Report 2024 – By Drug Class (Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes), By Species Type (Livestock Animals, Companion Animals), By Mode Of Administration (Oral, Parenteral, Topical), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the infectious disease therapeutics market?

Infectious disease therapeutics refers to the various treatments and interventions aimed at combating illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. The goal of infectious disease therapeutics is to either eliminate the infectious agent from the body or to control its replication and spread, thereby alleviating symptoms, preventing complications, and ultimately promoting recovery. For further insights on the infectious disease therapeutics market, request a sample here

How will the infectious disease therapeutics market drivers and restraints affect the infectious disease therapeutics market dynamics? What forces will shape the infectious disease therapeutics industry going forward?

The infectious disease therapeutics market major growth driver - Infectious Diseases On The Upswing A Global Health Concern . For further insights on the infectious disease therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the infectious disease therapeutics market?

The infectious disease therapeutics market size has grown strongly in recent years. It will grow from $132.14 billion in 2023 to $141.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, increasing incidence of viral diseases, growing awareness about diagnosis, rising demand for efficient and quick diagnostic testing, growing demand for cost-effective generic drugs, growing prevalence of infectious diseases, growing importance of antimicrobial stewardship. The infectious disease therapeutics market size is expected to see strong growth in the next few years. It will grow to $184.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing investments, expansion of clinical trial studies, increasing number of clinical trials, increasing focus on infectious disease prevention, increasing awareness about early diagnosis, growing awareness and funding. Major trends in the forecast period include partnerships, product approvals, investments, and research and developments in therapeutics. For further insights on the infectious disease therapeutics market, request a sample here

How is the infectious disease therapeutics market segmented?

The infectious disease therapeutics market is segmented
1) By Type: Drugs, Vaccines
2) By Disease: Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases
3) By End-User: Hospitals And Clinics, Retail Pharmacies, Research Organizations, Other End UsersFor further insights on the infectious disease therapeutics market, request a sample here

Which region has the largest share of the infectious disease therapeutics market? What are the other regions covered in the report?

North America was the largest region in the infectious disease therapeutics market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the infectious disease therapeutics market, request a sample here.

Who are the major players in the infectious disease therapeutics market?

Major companies operating in the infectious disease therapeutics market are Pfizer Inc., Roche Diagnostics Corporation, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, Thermo Fisher Scientific, AstraZeneca, Abbott Laboratories, Novartis International AG, Danaher Corporation, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceutical, Siemens Healthineers, Moderna Inc., Becton, Dickinson, and Company, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, BioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories, Qiagen N.V., Ortho Clinical Diagnostics, BioCryst Pharmaceuticals Inc. For further insights on the infectious disease therapeutics market, request a sample here.

What are the key trends in the infectious disease therapeutics market?

Major trend in the infectious disease therapeutics market - Corporate Initiatives In Infectious Disease Therapeutics Advancing Treatment, Resisting Resistance, and Promoting Global Health Equity. For further insights on the infectious disease therapeutics request a sample here.

What are the major opportunities in the infectious disease therapeutics market? What are the strategies for the infectious disease therapeutics market?

For detailed insights on the major opportunities and strategies in the infectious disease therapeutics market, request a sample here.

How does the infectious disease therapeutics market relate to the overall economy and other similar markets?

For detailed insights on infectious disease therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the infectious disease therapeutics industry?

For detailed insights on the mergers and acquisitions in the infectious disease therapeutics industry, request a sample here.

What are the key dynamics influencing the infectious disease therapeutics market growth? SWOT analysis of the infectious disease therapeutics market.

For detailed insights on the key dynamics influencing the infectious disease therapeutics market growth and SWOT analysis of the infectious disease therapeutics industry, request a sample here.